FindMeCure Ltd., a company focused on bringing clinical trials closer to patients, is pleased to announce a new member of their board of advisors as of July 2019 – Dr. Montserrat Barcelo Riera.
This decision has been driven by the company’s strategic expansion in new areas of the clinical research industry and Montserrat’s professional experience in business growth and global operations.
Dr. Barcelo is a leading figure in the global contract research industry and has been with TFS for the last 13 years. TFS is a top mid-sized full-service CRO dedicated to global clinical research with local presence and expertise. Dr. Barcelo has been one of the first employees outside of TFS headquarters in Sweden and played a key role in the company’s success to a leading European and later global CRO. She was also a member of the board of advisors within the company. Dr. Barcelo is also one of the founders of EjeCon, an organization of more than 700 women that are a part of company advisory boards and Board member of the well-known European analytical CRO Kymos Pharma services.
As a part of FindMeCure Ltd., Dr. Barcelo will be involved in the support of FindMePatients and its goal to improve patient recruitment. FindMePatients is designed to support Pharma, Biotech and CROs’ strategic clinical trial planning on a global level and in alignment with patients’ expectations and local regulations.